Climate change could exacerbate respiratory disease deaths during warm seasons

Global warming caused by climate change could exacerbate the burden of inpatient mortality from respiratory diseases during the warm season.

Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approval

The FDA granted accelerated approval to oral elafibranor (Iqirvo) for treating primary biliary cholangitis (PBC) in adults, drugmaker Ipsen announced on Monday. A first-in-class dual

June 12, 2024

New techniques in RNA engineering promise longer-lasting therapies

New methods to shape RNA molecules into circles could lead to more effective and long-lasting therapies, shows a study by researchers at the University of

August 27, 2024

Beneficial gut bacteria use mucus lining to stay in place, study finds

When it comes to gut health, it doesn’t just matter who’s invited to the party, but how they behave.

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.